Revive Therapeutics Announces Submission of IRB Approval for Phase 3 Clinical Trial Protocol for Bucillamine in COVID-19 Pharmaceutical Investing
Cardiol Therapeutics Initiates Health Canada Approved Phase 1 Clinical Study of CardiolRx(TM) Pharmaceutical Investing
Red Light Holland Commences Magic Truffles Growth Operation in the Netherlands, Months Ahead of Schedule Psychedelics Investing